rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mary Ellen Coe

Director

Company insider

Files Form 4 as: Director, Merck & Company; Director, Whole Foods Market.

In numbers

Trades disclosed
50
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
7 Dec 2016
Last trade
30 Sep 2026
Last filed
1 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
MRK Merck & CompanyDirector · Pharmaceuticals · last 30 Sep 20260 buys · 0 sells
Whole Foods MarketDirector · last 28 Aug 20170 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 1 Oct 2026MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K206.455 at $145.31filing
30 Jun 2026filed 1 Jul 2026MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K233.463 at $128.50filing
30 Jun 2026filed 1 Jul 2026MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K233.46 at $128.50filing
29 May 2026filed 2 Jun 2026MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$220K1,853.1 at $118.72filing
29 May 2026filed 2 Jun 2026MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$220K1,853.1 at $118.72filing
31 Mar 2026filed 1 Apr 2026MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K249.397 at $120.29filing
31 Mar 2026filed 1 Apr 2026MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K249.4 at $120.29filing
31 Dec 2025filed 5 Jan 2026MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K285.009 at $105.26filing
31 Dec 2025filed 5 Jan 2026MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K285.01 at $105.26filing
30 Sep 2025filed 2 Oct 2025MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K357.44 at $83.93filing
30 Jun 2025filed 2 Jul 2025MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K378.98 at $79.16filing
30 May 2025filed 3 Jun 2025MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$220K2,863.09 at $76.84filing
31 Mar 2025filed 2 Apr 2025MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K334.22 at $89.76filing
31 Dec 2024filed 3 Jan 2025MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K301.57 at $99.48filing
30 Sep 2024filed 1 Oct 2024MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K264.18 at $113.56filing
28 Jun 2024filed 2 Jul 2024MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K242.33 at $123.80filing
31 May 2024filed 4 Jun 2024MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$220K1,752.43 at $125.54filing
28 Mar 2024filed 29 Mar 2024MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K227.36 at $131.95filing
29 Dec 2023filed 2 Jan 2024MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K275.18 at $109.02filing
29 Sep 2023filed 3 Oct 2023MRK Merck & Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A$30K291.4 at $102.95filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Christine E. SeidmanDirector · Director at Merck & Co, filing Form 4 there in the last year
Surendralal Lanca KarsanbhaiDirector · Director at Merck & Co, filing Form 4 there in the last year
Jennifer ZacharyEVP, General Counsel · EVP, General Counsel at Merck & Co, filing Form 4 there in the last year
Chirfi GuindoEVP, Access, Policy & Comms · EVP, Access, Policy & Comms at Merck & Co, filing Form 4 there in the last year
Richard R. DeLucaEVP&Pres, Merck Animal Heallth · EVP&Pres, Merck Animal Heallth at Merck & Co, filing Form 4 there in the last year